Dermatology · Raleigh, NC
NPI
1225059637
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
309 W Millbrook Rd, Suite 171
Raleigh, NC, 27609
Phone (919) 788-9070
Groups this clinician bills Medicare through
Medicare paid, 2024
$260K
10,194 services
Medicare patients, 2024
884
Average age 75
Drug cost, 2024
$244K
2,093 prescriptions
Company payments, 2025
$606
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edith F Winter was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 3,600 times for 11 patients. In total Edith F Winter billed 10,194 services in 50 codes, and Medicare paid $260K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-15.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 3,600 | 11 | $1.32 | $4,765 |
| 17003 Destruction Skin Lesion | Office | 3,004 | 481 | $4.40 | $13K |
| 99214 Office E&M - Established | Office | 980 | 682 | $76.08 | $75K |
| 17000 Destruction Skin Lesion | Office | 823 | 592 | $35.90 | $30K |
| 99213 Office E&M - Established | Office | 437 | 320 | $55.30 | $24K |
| 11102 Skin Biopsy | Office | 295 | 251 | $60.59 | $18K |
| 17004 Destruction Skin Lesion | Office | 261 | 169 | $110.56 | $29K |
| 17110 Destruction Skin Lesion | Office | 232 | 201 | $73.01 | $17K |
| 11103 Skin Biopsy | Office | 137 | 86 | $34.49 | $4,725 |
| 99204 Office E&M - New | Office | 93 | 93 | $81.35 | $7,566 |
| 17263 Destruction Skin Lesion | Office | 48 | 41 | $111.54 | $5,354 |
| 99203 Office E&M - New | Office | 23 | 23 | $65.91 | $1,516 |
| 17262 Destruction Skin Lesion | Office | 18 | 18 | $101.81 | $1,833 |
| 96574 Skin | Office | 17 | 11 | $188.56 | $3,206 |
| 13101 Wound Repair - All Levels | Office | 17 | 15 | $248.22 | $4,220 |
By year: 2022 $362K for 8,141 services; 2023 $330K for 13,867 services; 2024 $260K for 10,194 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edith F Winter prescribed most often to Medicare patients was Ammonium Lactate, with 485 prescriptions and refills. In total Edith F Winter wrote 2,093 Medicare prescriptions that cost $244K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ammonium Lactate Generic | 485 | 527 | 292 | $6,137 |
| Metronidazole Generic | 474 | 578 | 326 | $19K |
| Ketoconazole Generic | 213 | 220 | 125 | $2,578 |
| Doxycycline Hyclate Generic | 145 | 221 | 66 | $4,011 |
| Triamcinolone Acetonide Generic | 117 | 117 | 101 | $317 |
| Hydrocortisone Generic | 87 | 87 | 74 | $344 |
| Hydroxyzine Hcl Generic | 79 | 106 | 42 | $951 |
| Mupirocin Generic | 44 | 44 | 43 | $283 |
| Fluorouracil Generic | 41 | 41 | 34 | $2,488 |
| Desonide Generic | 38 | 38 | 32 | $477 |
| Clobetasol Propionate Generic | 38 | 40 | 30 | $1,126 |
| Fluocinolone Acetonide Generic | 36 | 38 | 25 | $1,567 |
| Fluocinonide Generic | 35 | 35 | 28 | $841 |
| Clindamycin Phosphate Generic | 29 | 30 | 21 | $1,151 |
| Imiquimod Generic | 26 | 30 | 19 | $796 |
Brand drugs: 258 claims; generic drugs: 1,835 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edith F Winter $606 ($606 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $149.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 9 | $149 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $123 |
| Genzyme Corporation SNY | 4 | $88.93 |
| Galderma Laboratories, L.P. GALD.SW | 4 | $81.99 |
| Amgen Inc. AMGN | 2 | $40.13 |
| Janssen Biotech, Inc. JNJ | 2 | $33.69 |
| Incyte Corporation INCY | 1 | $27.32 |
| Lilly USA, LLC LLY | 1 | $24.61 |
| UCB, Inc. UCB.BR | 1 | $20.61 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $16.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.